NeuroPace (NPCE) Income towards Parent Company (2020 - 2026)
NeuroPace (NPCE) posted Income towards Parent Company of -$6.2 million for Q2 2026, up 5.59% on a QoQ basis from -$6.5 million in Q1 2026, and up 24.57% year-over-year from -$4.9 million in Q2 2025.
Analysis
NeuroPace (NPCE) Income towards Parent Company (2020 - 2026) Analysis & Trends
NeuroPace has reported Income towards Parent Company for 7 years, with the latest figure at -$6.2 million in Q2 2026.
- On a quarterly basis, Income towards Parent Company rose 24.57% year-over-year to -$6.2 million in Q2 2026; TTM through Jun 2026 was -$19.0 million, a 25.55% increase from a year earlier, with the FY2025 full-year figure at -$21.0 million, up 23.56% from the prior year.
- Income towards Parent Company was -$6.2 million for Q2 2026 at NeuroPace, up from -$6.5 million in the prior quarter.
- The five-year high for Income towards Parent Company was -$2.7 million in Q4 2025, with the low at -$12.6 million in Q2 2022.
- Average Income towards Parent Company over 5 years is -$7.8 million, with a median of -$7.5 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Income towards Parent Company slumped 101.12% in 2022, then surged 47.15% in 2025.
- Over 5 years, Income towards Parent Company stood at -$11.0 million in 2022, then jumped by 41.23% to -$6.5 million in 2023, then grew by 20.12% to -$5.2 million in 2024, then soared by 47.15% to -$2.7 million in 2025, then plunged by 125.69% to -$6.2 million in 2026.
- The last three Income towards Parent Company figures came in at -$6.2 million (Q2 2026), -$6.5 million (Q1 2026), and -$2.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.16 Mn |
| Mar 31, 2026 | -6.52 Mn |
| Dec 31, 2025 | -2.73 Mn |
| Sep 30, 2025 | -3.58 Mn |
| Jun 30, 2025 | -8.17 Mn |
| Mar 31, 2025 | -6.51 Mn |
| Dec 31, 2024 | -5.16 Mn |
| Sep 30, 2024 | -5.67 Mn |
| Jun 30, 2024 | -7.63 Mn |
| Mar 31, 2024 | -8.98 Mn |
| Dec 31, 2023 | -6.47 Mn |
| Sep 30, 2023 | -7.37 Mn |
| Jun 30, 2023 | -9.25 Mn |
| Mar 31, 2023 | -9.56 Mn |
| Dec 31, 2022 | -11.00 Mn |
| Sep 30, 2022 | -11.68 Mn |
| Jun 30, 2022 | -12.61 Mn |
| Mar 31, 2022 | -11.46 Mn |
| Dec 31, 2021 | -10.69 Mn |
| Sep 30, 2021 | -7.93 Mn |